League of Legends team owner embroiled in drug price hike controversy

[Administrator]

UPDATE 23/9/15 8:25AM Turing Pharmaceuticals has announced that it will scale back its pricing plans for Daraprim to ensure it remains affordable.
As reported by The Guardian this morning, CEO Martin Shrekli explained the company's new position to ABC World News Tonight:
“We've agreed to lower the price of Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit, and we think these changes will be welcome.”
Read more…


More...